FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Par Pharmaceutical Travoprost Ophthalmic Solution Recall

Travoprost Ophthalmic Solution USP, 0

Par Pharmaceutical, Inc. · Chestnut Ridge, NY

Risk level
Class II
Reported by FDA
Dec 7, 2016
Recall ID
D-0154-2017
Check your lot numberHow we source this data

Summary

Par Pharmaceutical recalled Travoprost Ophthalmic Solution starting Oct 5, 2016. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0154-2017 on Dec 7, 2016. Reason: Lack of Assurance of Sterility; damage to the internal portion of the dropper tip portion of the container. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility; damage to the internal portion of the dropper tip portion of the container

Product description

Travoprost Ophthalmic Solution USP, 0.004%, a) 2.5 mL and b) 5 mL bottles, Rx only, FOR USE IN THE EYES ONLY, Made in India, Distributed by: Par Pharmaceutical Cos., Inc, Spring Valley, NY 10977

Lot numbers, UPCs & expiration codes

a) G40814 - Exp. Date 09/2016, GA50089 - Exp. Date 12/2016, GA50259 - Exp. Date 01/2017, GA50657 - Exp. Date 03/2017, GA51073 - Exp. Date 06/2017, GA51651 - Exp. Date 09/2017, GA51652 - Exp. Date 09/2017, GA51722 - Exp. Date 09/2017, GA51723 - Exp. Date 09/2017, GA51760 - Exp. Date 10/2017, and GA51761 - Exp. Date 10/2017 b) GA45033 - Exp. Date 10/2016, GA50258 - Exp. Date 01/2017, GA50944 - Exp. Date 05/2017, GA50174 - Exp. Date 06/2017, GA51340 - Exp. Date 07/2017, GA51479 - Exp. Date 08/2017, and GA51762 - Exp. Date 10/2017

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0154-2017
Classification
Class II
Status
Terminated
Recall initiated
Oct 5, 2016
FDA report date
Dec 7, 2016
Quantity
a) 182,856 bottles; b) 59,448 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Par Pharmaceutical, Inc.

Original FDA data

Every field from FDA enforcement report D-0154-2017, exactly as published.

Show all FDA fields
City
Chestnut Ridge
State
NY
Status
Terminated
Country
United States
Event ID
75471
Address
1 Ram Ridge Rd
Code information
a) G40814 - Exp. Date 09/2016, GA50089 - Exp. Date 12/2016, GA50259 - Exp. Date 01/2017, GA50657 - Exp. Date 03/2017, GA51073 - Exp. Date 06/2017, GA51651 - Exp. Date 09/2017, GA51652 - Exp. Date 09/2017, GA51722 - Exp. Date 09/2017, GA51723 - Exp. Date 09/2017, GA51760 - Exp. Date 10/2017, and GA51761 - Exp. Date 10/2017 b) GA45033 - Exp. Date 10/2016, GA50258 - Exp. Date 01/2017, GA50944 - Exp. Date 05/2017, GA50174 - Exp. Date 06/2017, GA51340 - Exp. Date 07/2017, GA51479 - Exp. Date 08/2017, and GA51762 - Exp. Date 10/2017
Postal code
10977-6714
Report date
Dec 7, 2016
Product type
Drugs
Recall number
D-0154-2017
Classification
Class II
Recalling firm
Par Pharmaceutical, Inc.
Product quantity
a) 182,856 bottles; b) 59,448 bottles
Termination date
Jun 18, 2018
Reason for recall
Lack of Assurance of Sterility; damage to the internal portion of the dropper tip portion of the container
Voluntary / mandated
Voluntary: Firm initiated
Product description
Travoprost Ophthalmic Solution USP, 0.004%, a) 2.5 mL and b) 5 mL bottles, Rx only, FOR USE IN THE EYES ONLY, Made in India, Distributed by: Par Pharmaceutical Cos., Inc, Spring Valley, NY 10977
Distribution pattern
Nationwide
Recall initiation date
Oct 5, 2016
Initial firm notification
Letter
Center classification date
Nov 25, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0154-2017, published Dec 7, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls